Security key
525558201
LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT)
CUSIP: 525558201
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, $0.01 Par Value
- Total 13F shares
- 21,303,414
- Total 13F value
- $1,727,874,826
- Share change
- +328,228
- SEC-reported price per share
- $81.10
- Number of holders
- 297
- Value change
- +$26,162,852
- Number of buys
- 132
- Number of sells
- 141
- Shares outstanding
- 22,894,297
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
297
Top holders
10
LMAT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
LEMAITRE VASCULAR INC SEC filings
LEMAITRE VASCULAR INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 525558201
Recent filing periods:
Ownership snapshot
Top reported holders of LMAT - LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G
13F
Lead comparable stake: 14%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 14%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
14%
Conestoga Capital Advisors, LLC
8.1%
Copeland Capital Management, LLC
5.2%
VANGUARD GROUP INC
7%
GENEVA CAPITAL MANAGEMENT LLC
4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
Company
|
14%
|
$287,330,114
3,102,917 shares
|
-$75,053,782 | 31 Mar 2025 |
| Conestoga Capital Advisors, LLC |
13F
13D/G
Company · Conestoga Capital Advisors
|
8.1%
from 13D/G
|
$137,800,958
1,574,688 shares
|
— | 30 Sep 2025 |
| Copeland Capital Management, LLC |
13D/G
13F
Copeland Capital Management · Company
|
5.2%
|
$91,579,548
988,980 shares
|
$0 | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
7%
|
$140,023,613
1,600,087 shares
|
— | 30 Sep 2025 |
| GENEVA CAPITAL MANAGEMENT LLC |
13F
Company
|
4%
|
$79,830,852
912,248 shares
|
— | 30 Sep 2025 |
| FIRST TRUST ADVISORS LP |
13F
Company
|
3.6%
|
$72,541,151
828,947 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
297
Shares
21,303,414
Rows available
297
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
295
Q4 2025 holders
297
Holder diff
2
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend